CrystalGenomics Invites Co (XKRX:083790) Interest Expense : ₩-2,449.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2006. Start your Free Trial

What is CrystalGenomics Invites Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. CrystalGenomics Invites Co's interest expense for the three months ended in Mar. 2024 was ₩ -750.5 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-2,449.0 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. CrystalGenomics Invites Co's Operating Income for the three months ended in Mar. 2024 was ₩ -6,098.7 Mil. CrystalGenomics Invites Co's Interest Expense for the three months ended in Mar. 2024 was ₩ -750.5 Mil. CrystalGenomics Invites Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

CrystalGenomics Invites Co Interest Expense Historical Data

The historical data trend for CrystalGenomics Invites Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CrystalGenomics Invites Co Interest Expense Chart

CrystalGenomics Invites Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-5,764.52

-5,741.78

-2,434.90

-1,067.63

-2,094.58

CrystalGenomics Invites Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-328.27	-983.70	-157.49	-557.37	-750.46

CrystalGenomics Invites Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-2,449.0 Mil.

CrystalGenomics Invites Co (XKRX:083790) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

CrystalGenomics Invites Co's Interest Expense for the three months ended in Mar. 2024 was ₩-750.5 Mil. Its Operating Income for the three months ended in Mar. 2024 was ₩-6,098.7 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ₩28,921.8 Mil.

CrystalGenomics Invites Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

CrystalGenomics Invites Co did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

CrystalGenomics Invites Co (XKRX:083790) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CrystalGenomics Invites Co Ltd (XKRX:083790) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

5F, A-dong, Korea Bio Park, 694-1, Sampyeong-dong, Bundang-gu, Seongnam-si, Gyeonggi, KOR, 463-400

Website

http://www.crystalgenomics.com

CrystalGenomics Invites Co Ltd Formerly CrystalGenomics Inc is one of the leading biopharmaceutical company in Korea. The company is mainly engaged in the research and development and new drug development. It develops innovative new drug development projects such as eradication antibiotics and molecular targeted anticancer drugs. It focuses on arthritic medicines and antibiotics which kill resistant bacteria. It also offers medicines for cancer, obesity, asthma, and diabetes.

CrystalGenomics Invites Co (XKRX:083790) Headlines

No Headlines